OraSure Technologies (OSUR) Stock: Buy, Sell, or Hold?
OSUR - OraSure Technologies Inc
$3.37
0.12 (3.69%)
▲
5d:
-3.16%
30d:
-16.17%
90d:
-19.38%
WAIT
LOW Confidence
Analysis Updated: Sep 14, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When OSUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OSUR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OSUR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: OSUR is currently trading at $3.37, which is considered oversold relative to its 30-day fair value range of $3.44 to $3.91.
Technical Outlook: Technically, OSUR is in a uptrend. Immediate support is located at $3.15, while resistance sits at $3.68. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: OSUR scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+18.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSUR is in a uptrend. Immediate support is located at $3.15, while resistance sits at $3.68. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: OSUR scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+18.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.44 -
$3.91
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading below Wall St target ($4.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.44 -
$3.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.15
Resistance Level
$3.68
Current Trend
Uptrend
Technical data as of
Sep 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.11
Wall Street Target
$4.00
(+18.7%)
Revenue Growth (YoY)
-1.9%
Earnings Growth (YoY)
29.6%
Profit Margin
-43.7%
Share & Embed Analysis
Last updated: September 15, 2026 9:43 AM ET
Data refreshes hourly during market hours. Next update: 10:43 AM
Data refreshes hourly during market hours. Next update: 10:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSUR showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Kenneth J Mcgrath
BUY
32300 shares
2026-03-20
Manner Carrie Eglinton
BUY
32300 shares
2026-03-20
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 54 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 38 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 68 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$189 | 43 HOLD |
|
BLFS
BioLife Solutions Inc |
STRONG BUY
9 analysts |
$31 | 60 BUY |
